Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells

International Journal of Oncology

Volumn 27, Issue 5, 2005, Pages 1197-1206

  Meyer, Stefanie ^a   Hafner, Christian ^a   Guba, Markus ^a   Flegel, Stefanie ^a   Geissler, Edward K ^a   Becker, Bernd ^a   Koehl, Gudrun E ^a   Orso, Evelyn ^a   Landthaler, Michael ^a   Vogt, Thomas ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Ephrin B2; Invasion; Matrix interaction; Melanoma; Metastasis; Migration

Indexed keywords

EPHRIN B2;

ANIMAL; ARTICLE; BIOSYNTHESIS; CANCER INVASION; CELL ADHESION; CELL MOTION; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; MELANOMA; METASTASIS; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSEUDOPODIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN TUMOR;

ANIMALS; CELL ADHESION; CELL MOVEMENT; EPHRIN-B2; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; MELANOMA; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PSEUDOPODIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 33644639107     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.27.5.1197     Document Type: Article

References (38)

1. Tucker MA and Goldstein AM: Melanoma etiology: where are we? Oncogene 22: 3042-3052, 2003.
2. Balch CM, Buzaid AC, Atkins MB, et al. A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 88: 1484-1491,2000.
3. Nakamoto M and Bergemann AD: Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis. Microsc Res Tech 59: 58-67, 2002.
4. Varelias A, Koblar S A, Cowled PA, Carter CD and Clayer M: Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis. Cancer 95: 862-869, 2002.
5. Takai N, Miyazaki T, Fujisawa K, Nasu K and Miyakawa I: Expression of receptor tyrosine kinase EphB4 and its ligand ephrin-B2 is associated with malignant potential in endometrial cancer. Oncol Rep 8: 567-573, 2001.
6. Vogt T, Stolz W, Welsh J, et al. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas. Clin Cancer Res 4: 791-797,1998.
7. Orioli D and Klein R: The Eph receptor family: axonal guidance by contact repulsion. Trends Genet 13: 354-359,1997.
8. Drescher U: Eph family functions from an evolutionary perspective. Curr Opin Genet Dev 12: 397-402, 2002
9. Pasquale EB: The Eph family of receptors. Curr Opin Cell Biol 9: 608-615,1997.
10. Holland SJ, Gale NW, Mbamalu G, Yancopoulos GD, Henkemeyer M and Pawson T: Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature 383: 722-725,1996.
11. Frisen J, Holmberg J and Barbacid M: Ephrins and their Eph receptors: multitalented directors of embryonic development. EMBO J 18: 5159-5165,1999.
12. Holder N and Klein R: Eph receptors and ephrins: effectors of morphogenesis. Development 126: 2033-2044,1999.
13. Flanagan JG and Vanderhaeghen P: The ephrins and Eph receptors in neural development. Annu Rev Neurosci 21: 309-345, 1998.
14. Palmer A, Zimmer M, Erdmann KS, et al Ephrin B phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. Mol Cell 9: 725-737, 2002.
15. Cowan CA and Henkemeyer M: The SH2/SH3 adaptor Grb4 transduces B-ephrin reverse signals. Nature 413: 174-179, 2001.
16. Cowan CA and Henkemeyer M: Ephrins in reverse, park and drive. Trends Cell Biol 12: 339-346, 2002.
17. Tang XX, Brodeur GM, Campling BG and Ikegaki N: Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma. Clin Cancer Res 5: 455-460,1999.
18. Gale NW, Baluk P, Pan L, et al Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230: 151-160,2001.
19. Oike Y, Ito Y, Hamada K, et al Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells. Blood 100: 1326-1333,2002.
20. Adams RH, Wilkinson GA, Weiss C, et al. Roles of ephrin B ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13: 295-306, 1999.
21. Friedl P and Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374, 2003.
22. Gruss C and Herlyn M: Role of cadherins and matrixins in melanoma. Curr Opin Oncol 13: 117-123, 2001.
23. Ruiter D, Bogenrieder T, Elder D and Herlyn M: Melanomastroma interactions: structural and functional aspects. Lancet Oncol 3: 35-43, 2002.
24. Hegerfeldt Y, Tusch M, Brocker EB and Friedl P: Collective cell movement in: primary melanoma explants: plasticity of cell-cell interaction, betal-integrin function, and migration strategies. Cancer Res 62: 2125-2130, 2002.
25. Lawrenson ID, Wimmer-Kleikamp SH, Lock P, et al Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by Crkll and Rho-mediated signalling. J Cell Sci 115: 1059-1072, 2002.
26. Miao H, Burnett E, Kinch M, Simon E and Wang B: Activation of EphA2 kinase suppresses integrin function and causes focaladhesion-kinase dephosphorylation. Nat Cell Biol 2: 62-69, 2000.
27. Davy A and Robbins SM: Ephrin-A5 modulates cell adhesion and morphology in an integrin-dependent manner. EMBO J 19: 5396-5405, 2000.
28. Huynh-Do U, Stein E, Lane AA, Liu H, Cerretti DP and Daniel TO: Surface densities of ephrin-Bl determine EphBlcoupled activation of cell attachment through alphavbeta3 and alpha5betal integrins. EMBO J 18: 2165-2173,1999.
29. Huynh-Do U, Vindis C, Liu H, et al: Ephrin-Bl transduces signals to activate integrin-mediated migration, attachment andangiogenesis.JCellSci 115: 3073-3081,2002.
30. PrevostN,WoulfeDS,TognoliniM,era/: Signaling by ephrin B1 and Eph kinases in platelets promotes Rapl activation, platelet adhesion and aggregation via effector pathways that do not require phosphorylation of ephrin Bl. Blood 103: 1348-1355, 2004.
31. Stein E, Lane AA, Cerretti DP, et al Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev 12: 667-678,1998.
32. Santiago A and Erickson CA: Ephrin-B ligands play a dual role in the control of neural crest cell migration. Development 129- 3621-3632,2002.
33. Orioli D, Henkemeyer M, Lemke G, Klein R and Pawson T: Sek4 and Nuk receptors cooperate in guidance of commissural axons and in palate formation. EMBO J 15: 6035-6049,1996.
34. Easty DJ and Bennett DC: Protein tyrosine kinases in malignant melanoma. Melanoma Res 10: 401-411, 2000.
35. Easty DJ, Hill SP, Hsu MY, et al Up-regulation of ephrin-Al during melanoma progression. Int J Cancer 84: 494-501,1999.
36. Parsons JT, Martin KH, Slack JK, Taylor JM and Weed SA: Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19: 5606-5613, 2000.
37. Koolpe M, Dail M and Pasquale EB: An ephrin mimetic peptide that selectively targets the EphA2 receptor. J Biol Chem 277-46974-46979,2002.
38. Carles-Kinch K, Kilpatrick KE, Stewart JC and Kinch MS: Antibody targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior. Cancer Res 62: 2840-2847, 2002.